1. No category

This publication is not intended for distribution in the USA.
CLINICAL SUMMARY
A Prospective, Randomized
Study of Cross-Linked
and Non-Cross-Linked
Polyethylene for Total
Hip Arthroplasty at
10-Year Follow-Up
Engh CA Jr., Hopper RH Jr., Huynh C, Ho H,
Sritulanondha S, Engh CA Sr. A, The Journal
of Arthroplasty. 2012; 27: (8 Suppl 1) S2-7.10
230 hips randomized to receive either 5.0 Mrad crosslinked (MARATHON™) or non-cross-linked polyethylene
liners with a DURALOC® 100 Series cup.
The wear rate for cross-linked liners was 0.04 ± 0.06 mm/
yr, this is an 82% reduction in comparison to the reported
wear rate for non-cross-linked liners at 0.22 ± 0.13 mm/y. The
osteolysis threshold is generally considered to be 0.10 mm/yr.
None of the hips with cross-linked liners had a lesion
that was considered clinically important (at least 1.5cm2).
In comparison 22% off the un-revised hips with noncross-linked liners had clinically important lesions.
In the cross-linked group (116 MARATHON liners) the
10 year survivorship rate for wear related complications
with reoperation as an endpoint was 100%.
Polyethylene Wear and
Osteolysis After Cementless
Total Hip Arthroplasty
with Alumina-onHighly Cross-Linked
Polyethylene Bearings in
Patients Younger Than
Thirty Years of Age
Kim YH, Park JW, Patel CP, Kim DY.
The Journal of Bone and Joint Surgery
Inc. 2013; 95: 1088-1093.12
All patients were under the age of 30 and received a cementless
total hip replacement with a DURALOC cup, 28 mm alumina
forte ceramic femoral head and a MARATHON liner – the
majority of patients in the series continued to partake in high
demand activities following their total hip replacement.
The mean annual liner penetration rate was 0.031 ± 0.004 mm
per year. At the mean follow up of 10.8 years there were two
hips with a mean annual liner penetration rate over the osteolysis
threshold of 0.10 mm/year; however there was no evidence
of femoral or acetabular osteolysis in these two hips.
There were no polyethylene liner fractures.
At a mean follow up of 10.8 years there was no evidence
of femoral or acetabular osteolysis observed.
Kaplan-Meier survivorship analysis using revision as an end
point showed 100% survivorship of the acetabular and femoral
component at a mean 10.8 year follow up (95% CI, 98 to 100).
Over the last 15 years, the PINNACLE® Acetabular Cup System has grown to become
one of the most widely used and clinically successful modular acetabular cup systems
for hip replacement. Since its first implantation, the PINNACLE Acetabular Cup System
has been provided for more than 1.5 million patients1.
In 2014 the PINNACLE Acetabular Cup System was awarded a 10A ODEP rating by the Orthopaedic Data
Evaluation Panel.2
Australian Orthopaedic Association National Joint Replacement
Registry Data for the PINNACLE Acetabular Cup System
According to the 2014 AOANJRR (Table HT13 and HT14 shown below) annual report, the PINNACLE
Acetabular Cup System displayed better 10-year cumulative percent revision results than the 5.4%
cumulative percent revision reported for the cementless total hip replacement category in patients
with osteoarthritis excluding metal/metal prostheses with head size larger than 32 mm.3,4
Acetabular Component
Femoral Component
Implantations
Year 5
Year 7
Year 10
CORAIL
22250
3.1 (2.8,3.4)
3.6 (3.2,4.1)
4.8 (3.9,5.9)
SUMMIT®
3244
1.6 (1.2,2.2)
2.2 (1.6,3.1)
2.2 (1.6,3.1)
S-ROM®
2582
3.5 (2.8,4.4)
4.2 (3.3,5.2)
4.4 (3.5,5.5)
C-STEM AMT
1147
1.8 (0.9,3.4)
NA
NA
®
PINNACLE
™
PINNACLE Acetabular Cup System – Cumulative Percent Revision Estimates of All Bearing Combinations
with CORAIL, SUMMIT, S-ROM and C-STEM AMT (2014 AOANJRR, Table HT13 and HT14).3,5
National Joint Registry for England, Wales and Northern Ireland
Registry Data for the PINNACLE Acetabular Cup System
Based on joint replacement registry data from 2014, in 2013 the PINNACLE Acetabular
Cup System was the most implanted cementless cup in the United Kingdom.6
Combination
CORAIL /
PINNACLE
Implantations
Year 1
Year 3
Year 5
Year 7
Year 10
MoP
30,061
0.85 (0.75-0.96)
1.44 (1.30-1.61)
1.80 (1.61-2.01)
2.33 (2.04-2.66)
2.58 (2.19-3.04)*
MoM
11,871
0.85 (0.70-1.03)
2.39 (2.13-2.69)
5.14 (4.73-5.58)
8.82 (8.13-9.57)
-
CoP
8,483
0.60 (0.45-0.80)
1.14 (0.90-1.45)
1.74 (1.34-2.25)
1.84 (1.41-2.40)*
-
CoC
27,920
0.85 (0.75-0.97)
1.86 (1.69-2.06)
2.57 (2.33-2.84)
3.24 (2.86-3.66)
-
CoM
1,774
0.45 (0.23-0.90)
2.67 (1.99-3.58)
4.57 (3.37-6.19)
-
-
Kaplan-Meier estimates of the Cumulative Revision Rate Estimates by Bearing Articulation for CORAIL and
PINNACLE at 1, 3, 5, 7 and 10 years after the primary operation (2014 NJR, Table 3.10), (95% CI)7
Combination
C-STEM AMT Cemented
Stem / PINNACLE
Implantations
Year 1
Year 3
Year 5
Year 7
Year 10
2,984
0.91 (0.62-1.34)
1.34 (0.95-1.89)
2.11 (1.47-3.03)
2.11 (1.47-3.03)*
-
Kaplan-Meier estimates of the Cumulative Revision Rate Estimates for C-STEM AMT and PINNACLE
at 1, 3, 5, 7 and 10 years after the primary operation (2014 NJR, Table 3.9), (95% CI).8
* blue italics signify that fewer than 250 cases remained at risk at these time points
Fixation and Wear
With a Contemporary
Acetabular Component
and Cross-Linked
Polyethylene at Minimum
10-Year Follow-Up
Bedard N, Callaghan J, Stefl M, Williams
T, Liu S, Goetz D. Fixation and Wear
with Contemporary, The Journal of
Arthroplasty. 2014; 29: 1961-1969.9
The PINNACLE Sector cup (3 holes) was used in 149 hips and the
PINNACLE multi-hole cup was used in 1 hip | Supplementary fixation
of two or three screws was used in all bar one case in which no
screws were used | MARATHON liners were used in all cases.
Average linear wear rate was 0.05 mm/year and average
volumetric wear rate was 16.23 mm3 /year. The linear
steady state wear rate was 0.042 mm/year.
No cases of acetabular osteolysis reported and only
one case of femoral osteolysis was reported.
At 10 years follow up, survivorship with an end point
of reoperation for any reason was 99.2 ± 2.9%.
No PINNACLE porous coated acetabular shells
were revised at 10 Year follow up.
“Our results demonstrated that the cementless
acetabular component utilized in this cohort had
excellent durability at a minimum 10-year follow-up”
A Comparison of Second
and Third-Generation
Modular Cup Design,
Is New Improved?
Powers CC, Ho H, Beykirch SE, Huynh C,
Hopper RH, Engh CA Jr., Engh CA. The
Journal of Arthroplasty. 2010; 25: 514-521.11
This study compared the clinical outcomes of a matched
series of 42 DURALOC and 42 PINNACLE total hip
replacements with a mean follow-up of 5.9 years.
The median Harris Hip Score was excellent for both groups,
97 (57-100) for DURALOC and 98 (53-100) for PINNACLE.
The mean wear rate for DURALOC was 0.04 ± 0.08 mm/y
and 0.03 ± 0.09 mm/y for PINNACLE. (P=.81)
The mean volumetric wear based on the 2-dimensional
head penetration was 160 ± 98 mm3 for DURALOC
and 185 ±132 mm3 for PINNACLE. (P=.33)
The only difference in outcome between the two groups was the
incidence of pelvic osteolysis seen on CT (P = 0.005, 2-tailed Fisher
exact). No osteolysis was observed in the PINNACLE group. In the
DURALOC group there were 9 osteolytic lesions identified in 8 hips.
The authors conclude that the most likely reason for
the reduced incidence of retroacetabular osteolysis is
due to differences in the locking mechanisms.
Corail
F2L
ABGII
MoM
SPH-Blind
ASR
ABGII
(Shell/Insert)
976
49
44
2900
614
862
2.2
(1.7,
2.8)
(10.0,
(25.0,
(37.1,
3.1
(3.5,
7.0)
(4.5,
8.4)
(5.1,
9.2)
1.5 (2.0,
(0.9, 4.8)
2.6) 11.14.9
2.4
(1.5,12.4)
3.7) 26.66.1
3.1
(2.1,28.3)
4.5) 39.26.8
4.2
(3.0,41.3)
5.9)
Corail
H-Max
ABGII
DeltaMotion
Delta
TridentPF(Shell)
127
136
587
598
2313
0.8
(0.3,
2.1)
2.1
2.4 (1.1,
(1.9, 3.7)
3.1)
1.5
4.1 (0.6,
(3.3, 3.3)
5.0)
5.0 (4.2, 6.0)
6.0 (5.0, 7.2)
7.9 (6.5, 9.6)
Corail
M/L
TaperI
Accolade
Duraloc
Continuum
Trident (Shell)
57
13
331
1433
570
8746
1.4
(0.9,
2.2)
2.0
1.6 (1.1,
(1.3, 3.6)
1.9)
2.2
3.1)
2.9 (1.6,
(2.5, 3.2)
2.8
3.8 (2.0,
(3.4, 3.8)
4.2)
3.9
4.6 (2.9,
(4.1, 5.3)
5.2)
5.6
5.9 (4.1,
(5.1, 7.5)
6.9)
Corail
M/L
TaperI
Accolade
Pinnacle
Trilogy
Trident/Tritanium (Shell)
513
13
11
22250
569
648
1.6
(1.4,
1.7)
1.4
1.3 (0.7,
(0.6, 2.8)
2.5)
2.4
(2.2,
2.7)
1.7
1.9 (0.9,
(1.0, 3.2)
3.4)
3.1 (1.3,
(2.8, 4.4)
3.4)
2.4
3.6 (1.8,
(3.2, 6.0)
4.1)
3.3
4.8 (3.9, 5.9)
Corail
M/L
Taper Kinectiv Continuum
Pinnacle
Alloclassic
Allofit
68
36
187
966
1402
5304
2.2
(1.4,
3.3)
2.1
1.4 (1.5,
(1.1, 3.1)
1.8)
3.7
(2.6,
5.1)
3.0
2.3 (2.2,
(1.9, 4.2)
2.7)
6.1
3.1 (4.7,
(2.6, 7.9)
3.6)
9.0
3.6(6.8,
(3.1,11.7)
4.2)
4.9 (4.2, 5.8)
MoM
40
133
65
1020
2780
621
2.5
(1.7,
3.6)
1.9
1.3 (1.4,
(0.7, 2.5)
2.6)
3.4
(2.4,
4.7)
2.4
5.0 (1.9,
(3.5, 3.0)
7.0)
3.6
(2.6,
4.1(8.8,
(3.0,14.5)
5.6)
3.2
3.9) 11.3
4.0
(3.3,
4.9)
6.9 (2.5,
(5.1, 5.0)
9.3)
MoM
Epoch
Mallory-Head
Alloclassic
References
Trilogy
Mallory-Head
Durom
F2L
Metafix
Alloclassic
SPH-Blind
Trinity
Fitmore
49
16
91
614
679
1695
3.1
(2.0,
4.8)
2.0
2.8 (1.2,
(2.1, 3.4)
3.7)
4.9
(3.5,
7.0)
3.8
4.0 (2.0,
(3.2, 7.3)
5.1)
6.1
5.0 (4.5,
(4.0, 8.4)
6.2)
6.8
5.5 (5.1,
(4.5, 9.2)
6.8)
H-Max
Nanos
Alloclassic
Delta
PF Metal (Shell)
R3
Trabecular
12
334
598
513
996
2.1
(1.1, 2.0)
3.7)
0.7
(0.2,
2.2 (1.4,
3.3)
1.0
3.0 (0.4,
(2.0, 2.8)
4.3)
4.0 (2.8, 5.6)
4.0 (2.8, 5.6)
570
889
796
2.0
(1.1,
3.6)
1.0
0.5 (0.5,
(0.2, 1.9)
1.4)
1.6
0.7 (0.9,
(0.3, 2.7)
1.6)
2.2
1.0 (1.4,
(0.5, 3.5)
2.2)
13
55
57
569
508
3236
1.4
(0.7,
2.8)
3.2
1.6 (1.9,
(1.2, 5.1)
2.1)
1.7
(0.9,
3.2)
5.0
1.9 (3.4,
(1.4, 7.3)
2.4)
2.4
(1.3,
4.4)
6.6
2.0 (4.7,
(1.5, 9.2)
2.6)
M/L
Taper
Continuum
Natural
Hip file, DePuy
Fitmore
1. Data
on
Orthopaedics,29
139Inc.
Alloclassic
Trilogy
2.7
2.0 (1.8,
(0.9, 4.0)
4.5)
7.6
7.2(5.7,
(5.2,10.0)
9.9)
4.4 (4.7,
(3.2, 6.9)
6.1)
5.7
9.4 (7.5, 11.8)
7.6
6.4(5.7,
(5.2,10.0)
7.9)
4.2 (2.9, 6.1)
M/L Taper
Omnifit
Anthology
Trilogy
Secur-Fit
R3
3.3(5.9,
(1.8,10.7)
6.0) 10.8 (8.2, 14.0)
8.0
Mallory-Head
Polarstem
Apex
Mallory-Head
R3
Fin II
133
36
29
2780
2099
940
1.9
(1.4,
1.7
2.4)
1.8 (1.2,
(1.1, 2.5)
2.9)
2.4 (1.5,
(1.9,
3.0)
2.3
(1.6, 3.4)
3.7)
3.2
3.9)
2.3
(1.5,
3.7 (2.5,
(2.4, 3.4)
5.5)
4.0
5.0 (3.3, 4.9)
7.5)
5.7 (4.7, 6.9)
Natural
S-Rom
Citation Hip
Fitmore
Pinnacle
Trident (Shell)
29
87
40
889
2582
1147
1.0
(0.5,
2.1
2.7)
1.7 (1.6,
(1.1, 1.9)
1.6
(0.9,
2.7)
3.2
2.5 (2.6,
(1.7, 4.0)
3.5)
2.2
(1.4,
3.5)
3.5
3.0 (2.8,
(2.2, 4.4)
4.2)
2.7
(1.8,
4.0)
4.2
3.2 (3.3,
(2.3, 5.2)
4.4)
4.2
(2.9,
6.1)
4.4
3.9 (3.5,
(2.8, 5.5)
5.3)
Omnifit
SL-Plus
Corail
Trident
R3
ASR (Shell)
58
37
976
1245
1182
2900
1.9
(1.2,
2.8) 11.13.4
3.1
(2.3,12.4)
4.3) 26.64.0
(3.0,28.3)
5.3) 39.24.7
(3.6,41.3)
6.1)
2.0
(2.4,
4.8)
(2.9,
5.6)
2.2 (1.3,
(1.7, 3.0)
(10.0,
(25.0,
(37.1,
5.3 (4.1, 6.9)
Polarstem
Secur-Fit
Corail
Femoral
R3 Acetabular
DeltaMotion
Component
Quadra-H
Secur-Fit
Corail
Component
Versafit
Trident
(Shell)
Duraloc
S-Rom
Secur-Fit
ABGII Plus
Corail
Duraloc
Option
Trident
ABGII (Shell)
Pinnacle
31
150
189
513
666
5200
2928
22250
S-Rom
Summit
ABGII
Corail
MoM MoM
ABGII
(Shell/Insert)
ASR
Pinnacle
87
353
44
68
SL-Plus
Summit
ABGII
Epoch
EPF-Plus
Pinnacle
Trident (Shell)
Trilogy
94
50
136
40
SL-Plus
Summit
Accolade I
F2L
MoM
R3
Trident (Shell)
Pinnacle
SPH-Blind
37
40
331
49
2. Orthopaedic
Evaluation
Panel.
ratings.
Available
[Accessed 08/07/2014].
M/L
Taper Kinectiv Data
Continuum
2.1
(1.5,
3.1)
3.0
(2.2,
4.2)
Omnifit
Trident
(Shell)
1.9
3.1
4.3)
4.0
(3.0,
4.7
(3.6,
5.3 (4.1, 6.9)
36
1402
58
1245
Anthology
Reflection
(Shell)
1.4 (1.2,
(0.8, 2.8)
2.4)
1.6 (2.3,
(1.0,
2.7)
1.9 from
(1.2, 5.3)
3.1)URL:
2.1http//www.odep.org.uk
(1.3, 6.1)
3.4)
17 ODEP
887 product
9.4 (7.5, 11.8)
3. Australian
Orthopaedic
Association
Joint
Replacement
Annual
Report.
Adelaide:
Metafix
Trinity
2.0
(1.2,
3.4)
3.8
(2.0,
7.3)
Quadra-H
Versafit
1.9
(1.6,
3.1
3.2
16
679
140
6314
CLS
Allofit
1.4
(0.8, 2.3)
2.6)
3.4 (2.6,
(2.3, 3.7)
5.1) Registry.
3.8 (2.6, 3.8)
5.5)
5.2 (3.7,
7.3)
5.9
(4.2, 8.2) AOA; 2014. Available
38 National
780
Nanos
R3
0.7
(0.2,
2.0)
1.0
(0.4,
2.8)
S-Rom
Duraloc
1.5
2.4
3.4
5.0)
4.0
5.8)
4.7
513
314
666
CLS URL: https://aoanjrr.dmac.adelaide.edu.au/annual-reports-2014
Fitmore Option
1.9 (0.8,
(1.1, 2.8)
3.3)
4.0 (1.5,
(2.7, 3.9)
5.9)
4.4 (2.2,
(3.0,
6.4) HT13.
4.8 (2.7,
(3.4,Page
6.9)
5.1
(3.5, 6.7)
7.3)
646
from
Table
77.(3.3,
Table
Percent Revision
of Primary
Hip
with
Cementless
Omnifit
Secur-Fit
3.2
(1.9,
5.1)
5.0
(3.4,
7.3)
6.6
(4.7,
9.2) 8.0
10.8
(8.2,
SL-Plus
EPF-Plus
1.7
2.3)
2.8
3.6
(2.9,
4.5)
4.6
(3.7,
5.7)
6.6
(4.7,14.0)
9.3)
55
508
94
2256
Citation HT13: Cumulative
Vitalock
0.5 (1.2,
(0.2,Total
1.7) Conventional
2.2 (2.2,
(1.2, 3.6)
3.8)
2.8
(1.7,Replacement
4.0(5.9,
(2.6,10.7)
6.0)
6.5
9.2)
6.5 (4.7, 9.2)
32
555
Fixation
MoM
N 13
N
367
2099
713
587
Revised
140
6314
219
7580
57 Total
1433
1.7
2.4)
0.7
(0.3, 1.7)
0.8 (1.2,
2.1)
2.3
(1.5,
3.4)
2.1
1.5 (1.2,
(0.6, 3.7)
3.3)
2.3 (1.5, 3.4)
1.9
(1.6,
2.3)
1.5
1.4 (1.3,
(0.9, 1.8)
2.2)
3.1
(2.6,
3.7)
2.5
2.2 (2.2,
(1.6, 2.9)
3.1)
3.2
(2.6,
3.8)
3.1
2.8 (2.7,
(2.0, 3.6)
3.7
3.9 (3.2,
(2.9, 4.3)
5.3)
4.0
5.6 (3.5,
(4.1, 4.7)
7.5)
1.5
(0.8,
2.8)
1.2
1.8 (0.9,
2.4)
1.6
(1.4, 1.5)
1.7)
2.4
(1.5,
3.9)
1.9
3.1 (1.6,
(2.5, 2.3)
3.8)
(2.2,
2.7)
3.4
(2.2,
5.0)
2.4
4.1 (2.0,
(3.4, 2.9)
4.9)
3.1
(2.8,
3.4)
4.0
(2.7,
2.7
3.2)
5.3 (2.2,
(4.5, 5.8)
6.2)
3.6
(3.2,
4.1)
4.7
(3.3,
6.7)
3.6
6.8 (3.1,
(5.8, 4.3)
7.9)
4.8
(3.9,
5.9)
2582
1118
862
966
2.1
2.7)
1.2
(0.7,
1.5 (1.6,
(0.9, 2.0)
2.6)
2.2
(1.4,
3.3)
3.2
(2.6,
4.0)
3.5
(2.8,
4.4)
4.2
(3.3,
5.2)
6.5
(17.6,
(30.0,
2.4 (5.2,
(1.5, 8.1)
3.7) 19.86.1
3.1
(2.1,22.3)
4.5) 32.9
(3.0,36.1)
5.9)
3.7
5.1)
(4.7,
7.9)
9.0
(6.8,
11.7)
4.4
7.2 (3.5,
(5.2, 5.5)
9.9)
2256
3244
2313
1020
1.7
(1.2,
2.3)
1.0
2.4 (0.7,
(1.9, 1.4)
3.1)
2.5
(1.7,
3.6)
2.8
(2.2,
3.6)
1.4
4.1 (1.1,
(3.3, 2.0)
5.0)
3.4
(2.4,
4.7)
3.6
(2.9,
4.5)
1.6
5.0 (1.2,
(4.2, 2.2)
6.0)
(2.6,
5.0)
4.6
(3.7,
5.7)
2.2
6.0 (1.6,
(5.0, 3.1)
7.2)
4.1
(3.0,
5.6)
6.6
(4.7,
9.3)
2.2
7.9 (1.6,
(6.5, 3.1)
9.6)
4.4
(3.2,
6.1)
1182
784
8746
614
2.0
(1.3,
3.0)
1.5
1.6 (0.9,
1.9)
3.1
(2.0, 2.7)
4.8)
3.4
(2.4,
4.8)
2.2
2.9 (1.4,
(2.5, 3.5)
3.2)
4.9
(3.5,
7.0)
4.0
(2.9,
5.6)
3.2
3.8 (2.2,
(3.4, 4.8)
4.2)
6.1
(4.5,
8.4)
4.9
4.6 (3.5,
(4.1, 6.8)
5.2)
6.8
(5.1,
9.2)
7.6
5.9(5.4,
(5.1,10.8)
6.9)
(5.7,
10.0)
Revised
Total
N 265
N
150
5200
7605
65
621
13
569
1.2
(0.9,
1.5)
1.5
1.31(1.3,
2.6)
1.4
(0.7,
2.8)
Yr 1.8)
1.9
(1.6,
2.3)
2.3
(2.0,
5.0
(3.5, 2.7)
7.0)
1.7
(0.9,
3.2)
3 Yrs
2.4
(2.0,
2.9)
2.7
(2.2,
3.2)
2.6
(2.3,
3.1
(2.7,
3.5)
6.9
(5.1, 3.0)
9.3) 11.3
(1.3,
4.4)
3.3
(1.8,14.5)
6.0)
5 Yrs
7(8.8,
Yrs
3.6
(3.1,
4.3)
4.3
10(3.7,
Yrs 4.9)
1 Yr
3 Yrs
5 Yrs
7 Yrs
10 Yrs
13 Yrs
4.7(7.4,
(3.6,13.7)
6.2)
10.1
4. Australian
Orthopaedic
Association
Joint
Replacement
Annual
Report.
Adelaide: AOA; 2014. Available
Secur-Fit
DeltaMotion
0.7
(0.3,
1.7)
2.1
(1.2,
3.7)
Synergy
1.6
(0.9,
3.1
4.6 (3.4, 6.4)
7.5 (5.7,
9.9)
Accolade I
Trident/Tritanium
(Shell)
1.3
(0.6, 2.7)
2.5)
1.9 (2.1,
(1.0, 4.5)
3.4) Registry.
13
713
BHR
55
817
H-Max
Delta
PF
2.1
(1.1,
3.7)
11 National
648
12
598
N 219
N
Femoral
Secur-Fit
Trident
(Shell)
1.5
(1.3,
1.8)
2.5
(2.2,
2.9)
3.1
(2.7,
3.6) HT18.
3.7
(3.2,
4.3)
4.0
Synergy
R3
1.6
2.4
(1.8,
2.9
(2.2,
3.9)
Alloclassic
AllofitAcetabular
1.41(1.2,
2.3
(1.9, 3.0)
2.7)
(2.6,
3.6
(3.1,Page
4.2)
4.9
(4.2,
5.8)
7580
70
3161
187
5304
M/L
Taper
Continuum
2.0
(1.1,
3.6)
13
570
from
URL: https://aoanjrr.dmac.adelaide.edu.au/annual-reports-2014
Table
84.
Yr 2.2)
3 Yrs
5 Yrs
7 Yrs
10(3.5,
Yrs 4.7)
13 Yrs
Component
Component
MoM
Femoral
Secur-Fit
Synergy
Alloclassic
M/L
TaperPlus
MoM
Acetabular
Trident
(Shell)
Reflection
(Shell)
Durom
Trilogy
4.7
(3.6,
6.2)
5.4
13 (4.5,
Yrs 6.4)
Table
HT18:
Percent
Revision
of Primary
Hip Replacement by Fixation (Primary
Component
Component
Trabecular
Metal Cumulative
Continuum
4.9 (3.3,Total
7.1) Conventional
6.1 (4.2, 9.0)
Revised
28 Total
529
MoM
Summit
1.2
2.0)
6.5
(5.2,
8.1)
(17.6,
(30.0,
Taperloc
1.1
2.3
(1.7,
3.8)
Alloclassic
Fitmore
2.8 (0.7,
(2.1, 1.8)
3.7)
4.0 (1.6,
(3.2, 3.3)
5.1) 19.82.5
5.0
(4.0,22.3)
6.2) 32.95.5
(4.5,36.1)
6.8)
6.4 (5.2, 7.9)
ASR
353
1118
31
1653
91
1695
M/L
Taper Kinectiv Exceed
Continuum
2.1
(1.5,
3.1)
3.0
(2.2,
4.2)
36
1402
OA)
Tri-Lock
DeltaMotion
0.3
0.3
663
Trabecular Metal Diagnosis
Continuum
4.9 (0.1,
(3.3, 1.2)
7.1)
6.1 (0.1,
(4.2, 1.2)
9.0)
282
529
MoM
1.0
(0.7, 3.4)
1.4)
1.4
(1.1,
2.0)
1.6
(1.2,
2.2)
2.2
(1.6,
3.1)
2.2
(1.6,
3.1)
1.8
(0.9,
4.3
2.2 (1.4,
3.3)
3.0 (2.9,
(2.0, 6.5)
4.3) 7.3
4.0(5.3,
(2.8,10.0)
5.6)
(2.8,11.7)
5.6) 13.1
3244
50
514
33
996
1.9
2.5)
2.4
(1.9,
3.0)
3.2
(2.5,
3.9) 8.7
4.0(6.5,
(3.3,
4.9)
5.7(9.8,
(4.7,17.6)
6.9)
9.4 (7.5, 11.8)
133
2780
2.4
(2.0, 2.9)
3.2
(2.7, 3.8)
3.7 (3.2, 4.3)
4.1 (3.5, 4.7)
4.7 (4.1, 5.5)
4.7 (4.1, 5.5)
4234
0.3
0.3
663
N175
1.5
(0.9,
2.7)
2.2
(1.4,
3.2
(2.2,
4.8)
4.9
(3.5,
6.8)
1.7
(1.1,
2.6)
2.4
(1.7,
3.5)
2.8
4.1
4.3(5.4,
(3.1,10.8)
5.9)
0.5 (0.1,
(0.2, 1.2)
1.4)
0.7 (0.1,
(0.3, 1.2)
1.6)
1.0 (2.0,
(0.5, 4.1)
2.2)
2.0 (2.9,
(0.9, 5.6)
4.5) 7.6
40
784
41
1230
796
2.0
(1.2,
3.4)
3.8
(2.0,
7.3)
1629
679
1 Yr
3 Yrs
5 Yrs
7 Yrs
109.3
Yrs(8.9, 9.8) 12.4
13 Yrs
2.2
(2.1,
2.4)
3.9
(3.7,
4.2)
5.5
(5.3,
5.8)
7.3
(6.9,
7.6)
(11.4,
2068
37376
2.4
3.2
3.7
4.1
(3.5,
4.7)
4.7 (4.1, 5.5)
4.7
(4.1,13.5)
5.5)
175
4234
Total
1.6
(0.9,
2.7)
3.1
(2.1,
4.5)
4.6
(3.4,
6.4)
7.5(5.8,
(5.7,11.2)
9.9)
2.4
(1.4,
4.2)
4.1
(2.6,
6.2)
6.1
(4.3,
8.7)
(1.2, 2.9)
2.1)
1.9 (2.7,
(1.4, 3.8)
2.4)
2.0 (3.2,
(1.5, 4.3)
2.6) 8.1
55
817
0.7 (2.0,
(0.2,
2.0)
1.0
(0.4,
2.8)
35
502
574
3236
513
2.2
3.9
5.5
7.3
12.4(8.1,
(11.4,
13.5)
2068
37376
7489
824
19695
1.3) 2.4)
2.3) 4.2)
3.3) 5.8)
4.4) 7.6)
(5.5,(8.9,
6.4)9.8)
9.9)
R3
1.6
(1.2,
2.2)
2.4
(1.8,
3.0)
2.9
(2.2,
3.9)
Reflection (Shell)
1.4 (2.1,
(0.8,
2.4)2.1 (1.9,
(1.0,
1.9 (5.3,
(1.2,
3.1)4.0 (3.7,
2.1 (6.9,
(1.3,
3.4) 6.0 9.3
70
3161
17 164645
8871.1 (1.0,
Fitmore
1.0
(0.5,
1.9)
1.6 (3.7,
(0.9,
2.7)3.0 (2.8,
2.2
(1.4,
3.5)
2.7
(1.8,
4.0)
4.2
(2.9,
6.1) 9.0
29
889
TOTAL
7489
164645
Cementless
4551500 procedures
136311
(1.6,
1.8) 1.8)
2.8) 2.7)
3.5) 3.0)
(4.0,
4.3)10.7)
(5.2,
5.6)
7.6)6.4)
Synergy
Reflection
1.5
2.3
2.6
3.1
(2.7,
3.5)
4.3
(3.7,
4.9) 7.1 (6.7,
5.4 (4.5,
Apex Only combinations
Fin II with(Shell)
1.8 (1.3,
(1.1,
2.9)2.7 (2.6,
2.4 (2.0,
(1.6,
3.7)3.4 (3.3,
3.7 (2.3,
(2.4,
5.5)4.1 8.0
5.0(5.9,
(3.3,
7.5) 5.4
265
7605
29have
9401.7
Omnifit
Secur-Fit
3.2
(1.9,
5.1)
5.0
(3.4,
7.3)
6.6
(4.7,
9.2)
10.8
(8.2,
14.0)
Note:
over
been
listed.
55
508
Page | 77
Procedures using metal/metal
prostheses 77768
with head size1.2
than
have been
included
Hybrid
(1.1,
1.3)32mm
2.0) 3.3)
2.7) 3.8)
3.5) 6.1)
(4.5,(4.1,
5.0)6.9)
Taperloc
Exceed
1.1
1.8)
2.3
2.5
CLS
Allofit 1999
1.4 (0.7,
(0.8,
2.6)1.9 (1.8,
3.4 (1.6,
5.1)2.6 (2.5,
3.8 (1.7,
(2.6,
5.5)3.4 (3.2,
5.2 (3.6,
(3.7,
7.3) 4.8 5.3
5.9
(4.2,
8.2) 6.7 (6.1, 7.3)
31
38have 1653
780 larger
Omnifit
Trident
(Shell)
1.9
(1.2,
2.8)
3.1
(2.3,
4.3)
4.0
(3.0,
5.3)
4.7
Data
Period
September
–2211
31 500
December
2013
58
1245
Note:
Only 1
combinations
with
over
procedures
been
listed.
Summit
Taperloc
Alloclassic
Mallory-Head
VerSys
Tri-Lock
Summit
Taperloc
Alloclassic
Metafix
Pinnacle
Trabecular
Metal (Shell)
M2a
Mallory-Head
Trilogy
DeltaMotion
Mallory-Head
Trilogy MoM N
Pinnacle
Fixation Trinity
Trilogy
MoM
Revised
BHR
R3 MoM
Recap
Other
(1135)
VerSys
Synergy
Taperloc
Anthology
Nanos
Other (1135)
TOTAL
Cemented
Synergy
Anthology
Natural
Hip
Models with both fixed and exchangeable neck stems are reported separately.
Procedures using
metal/metal
with
size larger
32mm
have
included
MoM
TOTAL
7586prostheses
233774
Taperloc
1.8
(0.9,
3.4)
4.3
(2.9,
7.3
CLS MoM
Fitmore
1.9than
(1.1,
3.3)
4.0 been
(2.7, 6.5)
5.9)
4.4(5.3,
(3.0,10.0)
6.4)
50
514
31 head
646
Polarstem
R3
1.7
(1.2,
2.4) metal/metal
2.3
(1.5,
3.4)
2.3
(1.5,
3.4)
36
2099
denotes M2a
prosthesis combinations
that
have
used
large heads
(>32mm)
bearings
Models with both fixed and exchangeable neck stems are reported separately.
Taperloc
1.7
2.6)
2.4
(1.7,
3.5)
2.8
CitationMoM
Trident
2.7)32mm
2.5
3.0 (2.0,
(2.2, 4.1)
4.2)
41
1230
40
1147
Quadra-H
Versafit
1.9 (1.1,
(1.6,
2.3)
3.1
(2.6,
3.7)
3.2
(2.6,
3.8)
140
6314
denotes Mallory-Head
prosthesis
combinations
that have
used
large
(>32mm)
metal/metal
bearings
Note:
All procedures
using(Shell)
metal/metal
prostheses
with
head
sizeheads
larger
than
have
been
excluded
MoM
Taperloc
Citation
S-Rom
35
32
31
Vitalock
Recap
Duraloc Option
502
555
666
2.4
0.5 (1.4,
(0.2, 4.2)
1.7)
1.5
(0.8,
2.8)
4.1
2.2 (2.6,
(1.2, 6.2)
3.8)
2.4
(1.5,
3.9)
6.1
2.8 (4.3,
(1.7, 8.7)
4.5)
3.4
(2.2,
5.0)
8.7
4.8(6.5,
(3.4,11.7)
6.9) 13.1
5.1(9.8,
(3.5,17.6)
7.3)
4.1
3.2 (2.9,
(2.3, 5.6)
4.4)
4.3
3.9 (3.1,
(2.8, 5.9)
5.3)
8.1
(2.6,11.2)
6.0)
4.0(5.8,
(2.7,
5.8)
6.5 (3.3,
(4.7, 6.7)
9.2)
4.7
6.5 (4.7, 9.2)
Corail
2.2
(1.7, 2.8)
11.13.2
(10.0,
26.63.5
(25.0,
39.24.2
(37.1,
41.3)
ASR
976
2900
S-Rom
Pinnacle
2.1
(1.6,
2.7)
(2.6,12.4)
4.0) Registry.
(2.8,28.3)
4.4)
(3.3,
5.2)
4.4
(3.5, 5.5) AOA; 2014. Available
87 National
2582
5. Australian
Orthopaedic
Association
Joint
Replacement
Annual
Report.
Adelaide:
Corail
DeltaMotion
0.8 (1.2,
(0.3, 2.3)
2.1)
1.5 (2.2,
(0.6, 3.6)
3.3)
587
SL-Plus
EPF-Plus
1.7
2.8
3.6 (2.9, 4.5)
4.6 (3.7, 5.7)
6.6 (4.7, 9.3)
947
2256
Page | 77
from
URL:
https://aoanjrr.dmac.adelaide.edu.au/annual-reports-2014
Table
HT14.
Page
78.
Table HT14: Cumulative Percent Revision of Primary Total Conventional Hip Replacement with Hybrid Fixation
MoM
CorailPeriod 1 September
Duraloc1999 – 31 December 2013
57
Data
SL-Plus
R3
37
1433
1182
1.4 (1.3,
(0.9, 3.0)
2.2)
2.0
2.2 (2.4,
(1.6, 4.8)
3.1)
3.4
2.8 (2.9,
(2.0, 5.6)
3.8)
4.0
3.9 (2.9, 5.3)
5.6 (4.1, 7.5)
Table
Percent
of
Hip
with
Hybrid
Fixation
Corail HT14:
Pinnacle
1.6 (0.3,
(1.4,Total
2.4 (1.2,
(2.2, 3.7)
2.7)
3.1
(2.8,Replacement
3.4)
3.6 (3.2, 4.1)
4.8
(3.9, 5.9)
513
Secur-Fit
DeltaMotion
0.7
1.7)
2.1
Figure
HT11: Cumulative
Cumulative
PercentRevision
Revision
ofPrimary
TotalConventional
Conventional
Hip
Replacement
by Fixation
(Primary
13N 22250
713
Femoral
NPrimary
Acetabular
1 Yr 1.8)
CPR 2.5
3 Yrs
CPR3.6)
10 Yrs
MoM Component
OA)
Corail
2.2 (1.3,
(1.4,
3.3)
3.7
(2.6,CPR
5.1) 5 Yrs
6.1 (2.7,
(4.7,
7.9)7 Yrs
9.0
(6.8,
Pinnacle(Shell)
68
966
Secur-Fit
Trident
(2.2,
2.9)
3.1
3.7CPR
(3.2,11.7)
4.3)
4.0CPR
(3.5, 4.7)13 Yrs CPR
219
7580
Component Diagnosis
Revised
Total1.5
Femoral
N
N
HR adjusted for age and gender
Acetabular Component 150
1 Yr 1.5)
CPR 1.9
3 Yrs
5 Yrs
CPR2.9)
Yrs2.7
10 Yrs
CPR
2.52.4
(1.7,
3.6)
3.4
(2.4,CPR
4.7) 4.0
3.6
(2.6,
5.0)7
4.1CPR
(3.0,
4.4CPR
(3.2, 4.3)
6.1)13 Yrs4.7
(0.9,
(1.6,
2.3)
2.4
(2.0,
(2.2,
3.2)
3.6
(3.1,
(3.6, 6.2)
40 70
1020
5200
Revised
Total
9811.2
(1.6,
3.5) 3.1
(2.2,
4.4)
(2.9,
5.5)
5.2 (3.9,
6.9) 5.6)
8.1 (6.3,
10.4)
Cemented
vs Hybrid
0 - 1Mth:
HR=0.61
(0.46,
0.81),p<0.001
Epoch
Trilogy (Shell)
Secur-Fit
Plus
Trident
20%
Component
C-Stem
Duraloc
Cemented
49
353
SPH-Blind
ASR
Cementless
Pinnacle
Duraloc
Hybrid
12
50
Delta PF
Pinnacle
Pinnacle
MoM
16%
M/L Taper
Continuum
Summit
Pinnacle
CPCS
R3
C-Stem
AMT Joint
Pinnacle
National
Registry
for
MoM
M/L Taper
Trilogy
Synergy
BHR
Reflection
(Shell)
CPCS
R3
14%
Cumulative Percent Revision
6.
MoM
3.12.1
(2.0,
4.8)3.5) 3.1
4.9 (1.8,
(3.5, 4.5)
7.0) 19.8
(4.5,
8.4)4.9
6.8
(5.1,
9.2)
7.6 (5.7,
10.0)
614 700
(0.7,
2.0)
6.5
(5.2,
8.1)
(17.6,
22.3)
32.9
(30.0,
36.1)
1118
22
(1.2,
2.8
2.8
(1.8,
4.5)
(3.0,
7.9)
1Mth
- 6Mth:
(0.73, 1.15),p=0.469
70
9811.2
2.4
(1.6,
(2.2,
4.4)
4.0 6.1
(2.9,
5.5)
5.2
(3.9,
6.9)
8.1HR=0.92
(6.3,
10.4)
2.10.5
(1.1,
3.7)1.1)
5981147
(0.7,
1.4)
1.4 (1.8,
(1.1, 2.5)
2.0) 1.8
(1.2,
2.26Mth
(1.6,
3.1) HR=1.49
2.2 (1.6,
3244
- 1.5Yr:
(1.22, 3.1)
1.81),p<0.001
13
(0.2,
(0.7,
(0.9,
3.4)
22
7001.0
2.1
(1.2,
3.5) 1.4
2.8
4.5)
2.8 1.6
(1.8,
4.5)2.2)4.9 (3.0,
7.9)
1.5Yr+:
HR=1.40
(1.26,
1.54),p<0.001
2.01.7
(1.1,
3.6)2.4)
13 42
5702077
1.5
(0.9,
2.7)
2.2 (1.7,
(1.4, 3.3)
3.5) 2.5
(2.2,
4.9 (3.5, 6.8) 7.6 (5.4, 10.8)
40
(1.2,
2.4
(1.8,
3.5)
13784
1147
0.5
(0.2,
1.1) Ireland
1.4
(0.7,
2.5)
1.8 3.2
(0.9,
3.4)4.8) Report
England,
Wales
&
Northern
11th
Annual
Prostheses
Cementless
vs Hybrid
0 - 2Wk:2014.
HR=1.78 (1.47,
2.14),p<0.001 used in hip, knee, ankle, elbow and
1.41.7
(0.7,
2.8)2.4)
1.7 (1.7,
(0.9, 3.3)
3.2) 2.5
2.4
(1.3,
4.4)2.7 (2.0,
3.3 (5.7,
(1.8,
6.0)5.3 (3.7, 7.5)
13 42
5692077
(0.9,
2.7)
3.1
(2.1,
4.5)
(3.4,
7.5
55
67817
26681.6
1.0
(0.6,
1.4) 2.4
1.3
(0.9,
1.8)
1.8 4.6
(1.3,
2.4)6.4)
3.6) 9.9)
(1.2,
(1.8,
3.5)
2Wk - 3Mth: HR=1.39 (1.25, 1.55),p<0.001
shoulder
replacement
procedures70
2013.
Available
from
URL:
http://www.njrcentre.org.uk/njrcentre/default.aspx.
Table 4 (a). Page 8.
M/L Taper Kinectiv
Continuum(Shell)
2.11.1
(1.5,
3.1)
3.0
(2.2, 2.8)
4.2) 2.6
36
1402
Synergy
R3
(1.2,
2.2)
2.4
(1.8,
3.0)
(2.2,
3161
CPT
Allofit
15
8411.6
(0.6,
2.1) 1.6
(0.9,
(1.5,
4.5)
4.5)
CPCS
Reflection
67
2668
1.0
1.4)
1.3
1.8)
1.8 2.9
(1.3,
2.4)3.9)2.6
2.7 (1.5,
(2.0,
3.6)
5.3
(3.7, (0.94,
7.5) 1.37),p=0.187
3Mth
- 6Mth:
HR=1.13
F2L
Summit
C-Stem
18%
H-Max AMT
Summit
C-Stem
12%
Mallory-Head
Synergy
CPT
133
265
Mallory-Head
Reflection
(Shell)
Continuum
1.92.4
(1.4,
2.5)3.4) 3.3
2.4 (2.4,
(1.9, 4.6)
3.0)
(1.3,
1.8)
2.3
(2.0,
2.7)
278014161.5
7605
40
(1.7,
3.2 (2.5,
3.9)
2.6
(2.3, 3.0)
4.06Mth
(3.3,
4.9)HR=1.34
5.7(1.20,
(4.7,1.50),p<0.001
6.9)
9.4
3.1
(2.7,
3.5)
4.3
(3.7,
4.9)
5.4(7.5,
(4.5,11.8)
6.4)
- 2Yr:
CPT
Allofit
15
841 1.1 (0.6, 2.1) 1.6 (0.9, 2.8) 2.6 (1.5, 4.5) 2.6 (1.5, 4.5)
7. National
Registry
for England,
&2.0Northern
Ireland
11th
Annual
Report
2014. Prostheses used in hip, knee, ankle, elbow and shoulder
2Yr - 3Yr:
Metafix10% Joint
Trinity
(1.2,
3.4)3.3)
3.8 (2.7,
(2.0, 5.1)
7.3)
16 Wales
6791112
Taperloc
Exceed
(0.7,
1.8)
2.3
(1.6,
3.3)
(1.7,
31
1653
CPT
Trabecular
Metal (Shell)
47
2.2
(1.5,
4.9 2.5
(3.6,
6.5)3.8)6.2 (4.3,
8.8) HR=1.42 (1.21, 1.66),p<0.001
Continuum
40
14161.1
2.4
(1.7,
3.4) 3.7
3.3
(2.4,
4.6)
3Yr - 4Yr: HR=0.94 (0.79, 1.13),p=0.518
Nanos
R3
0.71.5
(0.2,
2.0)1.9)
1.0 (2.1,
(0.4, 5.1)
2.8) 3.1
513from
Taperloc
1.8
(0.9,
3.4)
4.3
(2.9,
6.5)
7.3
(5.3,3.7)
10.0)3.8
8.7
(6.5,
11.7)5.113.1
replacement
procedures
2013.
Available
URL:
http://www.njrcentre.org.uk/njrcentre/default.aspx.
Table 3.10. Page 51.
M2a
504 196
514
CPT
Trilogy
6131
(1.3,
2.4
2.9)
(2.7,
(3.3,
4.4)
(4.3,(9.8,
6.1)17.6)
Trabecular
Metal
(Shell)
47
1112
2.2
(1.5,
3.3)
3.7
(2.7,
4.9
(3.6,
6.5)
6.2
(4.3,
8.8)
8%
MoM
4Yr - 4.5Yr: HR=1.38 (1.04, 1.81),p=0.023
Natural
Hip
Taperloc
Elite
Plus
CPT
Fitmore
Mallory-Head
Duraloc
Trilogy
1.02.0
(0.5,
1.9)3.0)
1.6 (2.7,
(0.9, 5.0)
2.7) 5.4
2.2
(1.4,
3.5)7.3
2.7 (2.9,
(1.8,
4.0)
4.2 (3.1,
(2.9,
6.1)
29 196
8891078
(1.1,
2.6)
2.4
(1.7,
3.5)
(2.0,
4.1
5.6)
4.3
5.9)
41
1230
98
(1.3,
(4.2,
7.0)
9.1)
9.9
14.2 (10.2, 19.4)
61311.7
1.5
1.9) 3.6
2.4
(2.1,
2.9)
3.1 2.8
(2.7,
3.7)4.1)
3.8 (5.8,
(3.3,
4.4)HR=0.93
5.1(8.0,
(4.3,
6.1)
4.5Yr+:
(0.84,12.0)
1.02),p=0.121
Polarstem
Exeter V40
R3
Hemispherical
ABGII
36
Exeter V40
R3
Pinnacle
6%
Omnifit
Secur-Fit
3.2
(1.9,
5.1)2.5)
5.0 (1.6,
(3.4, 3.4)
7.3)
6.6
(4.7,
9.2)
8.0
(5.9,
10.7)
10.8
(8.2,
14.0)
8. National
Registry for England,
&2.4
Northern
11th
Annual
Report
2014.
Prostheses
used
55 Wales
5081218
Taperloc
(1.4,
4.2)
4.1
(2.6,
6.2)
6.1
(4.3,
8.7)
8.1
Recap
35
vs
Cemented
0(5.8,
- 1Mth:
HR=2.52
(1.91,
3.33),p<0.001
Exeter
Vitalock
59
1.6
(1.0,
2.3
2.5
(1.8,
3.6)
3.3
(2.4,
4.5)11.2)
4.7(8.0,
(3.6,
6.2)
(4.4,
7.4) in hip, knee, ankle, elbow and
Elite
Plus Joint
Duraloc
98502
1078
2.0
(1.3,
3.0) Ireland
3.6
(2.7,
5.0)
5.4Cementless
(4.2,
7.0)
7.3
(5.8,
9.1)
9.9
12.0)
14.25.7
(10.2,
19.4)
- 3Mth:
HR=1.36
(1.10, 6.9)
1.67),p=0.003
OmnifitV40
Trident (Shell) procedures58
(1.2,
2.8)
3.1
(2.3, 2.4)
4.3) 2.1
(3.0,
4.71Mth
(3.6,
6.1)3.7
5.3 (4.1,
1245
Exeter
ABGII
35
1064
(0.6,
2.0)
(0.9,
(1.4,
3.2)
4.5)
5.2)
shoulder
2013.
Available
from
URL:
http://www.njrcentre.org.uk/njrcentre/default.aspx.
Table 3.9. Page 50.
Vitalock
59
12181.91.1
1.6
(1.0,
2.5) 1.4
2.3
(1.6,
3.4)
2.5 4.0
(1.8,
3.6)5.3)3.2
3.3 (2.2,
(2.4,
4.7 (2.6,
(3.6,
6.2)
5.7 (4.4, 7.4)
4% replacement
3Mth - 1.5Yr: HR=1.01 (0.87, 1.18),p=0.888
2%
MoM
(1.2,
2.4)3.5)
2.3 (0.9,
(1.5, 4.9)
3.4) 2.1
(1.5,
20991064
20
6491.72.0
(1.2,
(2.0,
3.4 2.3
(2.2,
5.3)
5.3)
35
1.1
(0.6,
2.0) 3.2
1.4
2.4)
(1.4,
3.2)3.4)3.4
3.2 (2.2,
4.5) 3.7 (2.6, 5.2)
1.5Yr - 3Yr: HR=0.99 (0.85, 1.14),p=0.836Page | 77
Quadra-H
Versafit1999 –J,31Stefl
1.90.5
(1.6,
2.3)1.1)
3.1 (0.5,
(2.6,
3.7) 1.0
3.2
(2.6,
3.8)1.7
140 23
6314T,1249
Data
Period
1 September
December
Exeter
V40N,
Mallory-Head
(0.2,
1.6)
(0.6,
1.8)
(1.0,
3.3
(2.1,(0.54,
5.0)0.88),p=0.003
9. Bedard
Callaghan
M, 2013
Williams
Liu
S,
Goetz
D.
Fixation
Wear
Contemporary
Acetabular Components
Hemispherical
20
649
2.0
(1.2,
3.5) 0.9
3.2
(2.0,
4.9)
3.4and
(2.2,
5.3)
3.4with
(2.2,
5.3)
3Yr2.9)
- 3.5Yr:
HR=0.69
S-Rom
Duraloc Option
1.51.1
(0.8,
2.8)2.0)
2.4 (1.2,
(1.5, 3.2)
3.9) 2.2
(2.2,
4.03.5Yr
(2.7,
5.8)3.3
4.7(0.64,
(3.3,
6.7)
31 19
0%
- 5Yr:
HR=0.76
ExeterCross-Linked
V40
Pinnacle
(0.6,
2.0
(1.4,
3.6)
5.8)
Mallory-Head
236661037
1249
0.5
(0.2,
1.1)Journal
0.9
(0.5,
1.6)
1.0 3.4
(0.6,
1.8)5.0)3.1
1.7 (1.6,
(1.0,
2.9)
(2.1,
5.0)0.90),p=0.001
and
Polyethylene
at
10-Year
Follow-Up.
of
Arthroplasty.
2014;
29:
1961-1969.
0
1
2
3
4
5
6
7
10
11
12
13
S-Rom
Pinnacle
3.2 (2.6,
4.0)
3.5 (2.8, 4.4)
4.25Yr+:
(3.3,HR=0.66
5.2) (0.59,
4.40.74),p<0.001
(3.5, 5.5)
87
2582 8 2.19(1.6, 2.7)
22
1021 1.1 (0.6, 2.0) 2.3
2.0 (1.4,
(1.2, 3.7)
3.2) 3.8
2.2 (2.3,
(1.4, 6.3)
3.6) 3.1 (1.6, 5.8)
19Procedure
1037
Years Since Primary
SL-Plus
EPF-Plus
1.71.1
(1.2,
2.3)1.3)
2.8 (1.6,
(2.2, 1.9)
3.6) 2.4
3.6
(2.9,
4.6 (3.7,
6.6 (4.7,
225636720
Exeter V40
(Shell)RH Jr., Huynh94C,833
(1.0,
(2.2,
2.6)
(2.8,
3.3) 5.7)4.4Randomized
(4.0,
4.9) 9.3)
R3
22
1021
(0.6,
2.0) 1.8
2.3
(1.4,
3.7)
3.8CA
(2.3,
6.3)4.5)
10.Engh
CA Jr., Trident
Hopper
Ho
H,
Sritulanondha
S, Engh
Sr.
A 3.1
Prospective
Study of Cross-Linked and Non-CrossSL-Plus
R3
(1.3,
3.0)1.6)
3.4 (1.0,
(2.4, 2.9)
4.8) 2.4 4.0
(2.9,
37 833
118236720
Exeter V40
Trident/Tritanium
20
15092.01.0
(0.6,
Trident
(Shell) (Shell)
1.1
(1.0,
1.3) 1.7
1.8
(1.6,
1.9)
(2.2,
2.6)5.6)3.1 (2.8, 3.3) 4.4 (4.0, 4.9)
Linked
Polyethylene
for
Total
Hip
Arthroplasty
at
10
–Year
Follow
Up,
Journal
of
Arthroplasty.
2012;
27:
(8 Suppl 1) S2-7
Secur-Fit
DeltaMotion
0.7
(0.3,
1.7)
2.1
(1.2,
3.7)
13
713
Exeter V40
Trilogy
18
598 1.7 (0.9, 3.1) 2.5 (1.5, 4.1) 2.7 (1.6, 4.5) 3.0 (1.8, 4.8) 4.9 (2.6, 9.1)
Exeter V40
Trident/Tritanium (Shell)
Secur-Fit
Trident (Shell)
Exeter
V40 at Risk
Vitalock
Number
0 Yr
1219
Yr
20 1509 1.0 (0.6, 1.6) 1.7 (1.0, 2.9)
(1.3,
1.8)1.5) 1.7
2.5 (1.2,
(2.2,
2.9) 2.3 3.1
(2.7,
3.7 (3.2,
4.0 (3.5,
758019591.5
62
2.3)
(1.7,
3.1)
3.7) 4.3)
(2.5,
4.1) 4.7) 13 Yrs
30.9
Yrs(0.6,
5 Yrs
73.6)
Yrs2.8 (2.2,
103.2Yrs
Exeter V40
Trilogy
18
598 1.7 (0.9, 3.1) 2.5 (1.5, 4.1) 2.7 (1.6, 4.5) 3.0 (1.8, 4.8) 4.9 (2.6, 9.1)
11.Powers
CC, Ho
H, (Shell)
Beykirch SE, Huynh
C, Hopper
RH,
Engh
CA2.8)
Jr.,2.4Engh
CA.3.1
A Comparison
Second4.7and
ThirdSecur-Fit
Plus
Trident
(0.9,
1.5)2.1)
1.9 (1.3,
(1.6,
2.3)
(2.0,
2.7 (2.2,
3.6 of
(3.1,
150 41
5200
MS
30 V40
Allofit
1365
1.4
(0.9,
(1.7,
3.4)
4.4)
(2.9,
5.7)
Exeter
Vitalock
62
19591.215104
0.9
(0.6,
1.5) 1.9
1.7
(1.2,
2.3)
2.3 2.4
3.1)2.9)
2.8 (2.2,
3.7) 3.2)4.0
3.2
(2.5,
4.1) 4.3)
Cemented
19695
18129
12030
8969
4321
410 (3.6, 6.2)
Summit
(0.7,
2.0)2.5)
6.5Journal
(5.2,
8.1) 19.8
(17.6,4.1)
22.3)
32.9
(30.0,
ASR
353
1118
Generation
Modular
Cup
Design,
Is
New
Improved?
The2.9
of (2.6,
Arthroplasty.
2010;
514-521.839
Omnifit
Trident
1.8
(1.3,
(2.3,
3.7)
3.2
3.5
(2.8,
4.4)36.1)14938
3.9
(3.1,
MS
30
Allofit (Shell)
41 2334
13651.282931
1.4
(0.9,
2.1)
1.9
(1.3,
2.8)
2.4
(1.7,
3.4)
3.1
(2.2,
4.025:
(2.9, 4.9)
5.7)
Cementless
136311
116379 73
56072
37444
MoM
Summit
Spectron
Omnifit EF
MoM
Pinnacle
BHR
Trident
(Shell)
Hybrid
77768
MoM
Summit
12.Kim
YH,EF ParkR3
JW,
Pinnacle
MoMPatel CP,
Spectron
BHR
(0.7,
1.4)2.0)
1.4 (2.3,
(1.1, 4.8)
2.0) 3.2
(1.2,
2.2)
2.2 12.8)
(1.6,
2.2 (1.6,
50 39
32442334
5321.051070
0.8
(0.3,
(1.8,
6.6 1.6
(4.7,
9.4)
9.2
73
1.8
(1.3,
2.5) 2.9
3.7)
(2.6,
4.1)
3.5(6.6,
(2.8,
4.4) 3.1)3.9
(3.1,
4.9) 3.1)
67968
36475
24233
9968
817
(0.9,
2.7)2.4)
2.2 (1.8,
(1.4,
3.5) 2.6
(2.2,
4.9 12.8)
(3.5, 6.8) Total
7.6 (5.4,Hip
10.8)Arthroplasty with Alumina-onKim DY.40Polyethylene
Wear
Osteolysis
After
Cementless
27
(1.0,
2.6
3.8)
(1.8,
3.8)
397841197
5321.51.5
0.8
(0.3,
2.0)and
2.9
4.8)
6.6 3.2
(4.7,
9.4)4.8)9.2
(6.6,
Synergy
(0.9,
2.7)1.4)
3.1 (1.6,
(2.1, 2.4)
4.5)Than
(3.4,
7.5 (5.7,
9.9)6.2 (5.3,
BHR
Spectron EF
Reflection
(Shell)
214
1.1
(0.8,
2.0
2.8
(2.3,
3.3)
3.8 (3.2,
4.4)Age.
7.2)2013;
11.1 (8.7,
Highly
Cross-Linked
Polyethylene 55
Bearings
in1.6Patients
Thirty
of
JBJS.
95:14.1)
1088-1093
R3
278174969
1197
1.5
(1.0,
2.4)Younger
2.6
(1.8,
3.8)
2.6 4.6
(1.8,
3.8)6.4)Years
Note: All procedures using
MoM metal/metal prostheses with head size larger than 32mm have been excluded
Synergy
Other
(764)
Spectron
EF
Synergy
Other (764)
TOTAL
Taperloc
R3
Reflection
(Shell)
Reflection (Shell)
Exceed
(1.2,
2.2)1.4)
70 824
316115668
1.8
(1.6,
2.0)
214
49691.61.1
(0.8,
(1.3,
1.8)2.0)
265 2939
7605
824
156681.51.8
(1.6,
91240
31
1653
1.1 (0.7, 1.8)
2.4 (2.9,
(1.8, 3.5)
3.0) 2.8
(2.2,
3.2
4.5 2.9
(4.1,
4.9)
9.1 (8.2,
10.0)
2.0
(1.6,
2.4)
(2.3,
3.3)3.9)5.7
3.8 (5.3,
(3.2, 6.1)
4.4) 7.5
6.2 (6.9,
(5.3, 8.0)
7.2) 11.1
(8.7, 14.1)
2.3 (2.9,
(2.0, 3.5)
2.7) 4.5 2.6
(2.3,
3.1 (2.7,
4.3 (3.7,
5.4 10.0)
(4.5, 6.4)
3.2
(4.1,
4.9)3.0)5.7 (5.3,
6.1) 3.5)7.5 (6.9,
8.0) 4.9)9.1 (8.2,
2.3 (1.6, 3.3)
2.5 (1.7, 3.8)
TOTALOnly combinations with over 500 procedures have
2939
91240
Note:
been
listed.
Taperloc
1.8than
(0.9,32mm
3.4) have
4.3 been
(2.9, 6.5)
7.3 (5.3, 10.0)
M2a MoM
50 head 514
Procedures using
metal/metal prostheses with
size larger
included
Note: MoM
Only combinations with over 500 procedures have been listed.
Taperloc denotes Mallory-Head
1.7 (1.1,
2.6) metal/metal
2.4 (1.7, 3.5)
2.8 (2.0, 4.1)
prosthesis combinations that have
used
large heads
(>32mm)
bearings
41
1230
Procedures using metal/metal prostheses with head size larger than 32mm have been included
MoM
MoM
Taperloc
2.4 (1.4,
4.2) metal/metal
4.1 (2.6, 6.2)
6.1 (4.3, 8.7)
35 used502
denotes Recap
prosthesis combinations that have
large heads
(>32mm)
bearings
8.7 (6.5, 11.7) 13.1 (9.8, 17.6)
4.1 (2.9, 5.6)
4.3 (3.1, 5.9)
8.1 (5.8, 11.2)
All analysis was carried out by DePuy Synthes, the NJR do not vouch for the accuracy of the interpretation.
Page | 77
Data Period 1 September 1999 – 31 December 2013
Johnson & Johnson Medical Limited PO BOX 1988, Simpson Parkway, Livingston, West Lothian,
EH54 0AB, United Kingdom.
Page | 78
Data Period 1 September 1999 – 31 December 2013
Page | 78
Incorporated
and registered in Scotland under company number SC132162.
Data Period 1 September 1999 – 31 December 2013
Data Period 1 September 1999 – 31 December 2013
DePuy Orthopaedics, Inc.
700 Orthopaedic Drive
Warsaw, IN 46582
USA
Tel: +1 (800) 366 8143
Fax: +1 (574) 267 7196
Page | 84
DePuy International Ltd
St Anthony’s Road
Leeds LS11 8DT
England
Tel: +44 (0)113 270 0461
Fax: +44 (0)113 272 4101
depuysynthes.com
©Johnson & Johnson Medical Limited. 2015. All rights reserved.
CA#DSEM/JRC/1214/0218 Issued: 04/15
DePuy (Ireland)
Loughbeg
Ringaskiddy
Co. Cork
Ireland
Tel: +353 21 4914 000
Fax: +353 21 4914 199
0086